Status:
UNKNOWN
7.5F Versus 9.2F Flexible Ureteroscopy for the Treatment of 1-2cm Renal Calculi on Postoperative Infection
Lead Sponsor:
The First Affiliated Hospital of Guangzhou Medical University
Conditions:
Kidney Stones
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Ureteroscopic lithotripsy (RIRS) is the first-line treatment for 1-2 cm upper urinary tract stones, and the stone clearance rate can reach 81.4% - 92.5%. Fever after RIRS is the most common infection ...
Eligibility Criteria
Inclusion
- Agree to receive ureteroscopy
- Aged 18-70 years. 3.1-2cm kidney stones
Exclusion
- Combined with middle and lower ureteral calculi, surgical operation other than RIRS is required;
- Patients with abnormal anatomical structure, ureteral stenosis and urinary diversion, such as ectopic kidney, horseshoe kidney and duplicate kidney;
- Patients who have undergone nephrostomy;
- Severe cardiopulmonary insufficiency;
- Pregnant women.
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05231577
Start Date
February 1 2022
End Date
August 31 2022
Last Update
February 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Urology, Minimally invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong,China, China, 510230